A Two-Part, Double-Blind, Third Party Open (Sponsor), Dose-Rising, Placebo-Controlled and Open-Label Exploratory Food Effect Study of the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of CXA-10 in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 04 May 2016
At a glance
- Drugs CXA 10 (Primary)
- Indications Renal failure
- Focus Adverse reactions; First in man
- Sponsors Complexa
- 19 Nov 2015 According to Complexa media release, status changed from recruiting to completed.
- 12 Nov 2015 According to Complexa media release, results were presented at the American Society of Nephrology's Kidney Week 2015.
- 12 Jan 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov